Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9307745.
- Also identified by PMC identifier 2431370.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A patient with a pituitary adenoma secreting follicle-stimulating hormone with co-existent primary hyperaldosteronism is described. After his second transsphenoidal surgery, the patient developed a Staphylococcus aureus pituitary abscess. Symptoms improved after abscess drainage. Subsequent cabergoline therapy arrested the deterioration of symptoms. and decreased serum follicle-stimulating hormone concentrations. Cabergoline may be a useful treatment for aggressively growing non-prolactin-secreting pituitary adenomas.
Medical subject headings
- Adenoma
- Antineoplastic Agents
- Dopamine Agonists
- Ergolines
- Follicle Stimulating Hormone
- Pituitary Neoplasms